Kyntra Bio CEO Acquires Shares Amid Market Downtrend
Thane Wettig, Chief Executive Officer and director at Kyntra Bio, Inc. (NASDAQ:KYNB), recently purchased a block of the company's common stock. This acquisition occurred on May 14, 2026, totaling $19,852 for 2,800 shares, even as the stock has experienced significant declines year-to-date. The transaction highlights insider activity against a backd…